The Europe Neurovascular Catheters Market would witness market growth of 6.4% CAGR during the forecast period (2023-2029).
The market is experiencing growth due to the rising demand for a more natural and aesthetically pleasing appearance across all age groups, as well as a reduction in blood loss during minimally invasive surgeries. Implementing such procedures can enhance the patient experience by reducing trauma and promoting faster recovery compared to invasive procedures. Minimally invasive neurovascular procedures are expected to experience an increase in demand due to the benefits of neurovascular catheters, such as reduced blood loss and faster recovery time.
The demand for endoscopic brain surgery, which has increased as a result of the continuing advancement of endoscopic surgical procedures and single-incision laparoscopic, is a significant factor that is driving the market. Because of these improvements, conventional approaches to brain surgery will no longer be utilized, which will lead to an increase in the need for neurovascular catheters and other equipment utilized in the practice of neurovascular medicine.
The cases of the brain aneurysms in Europe are experiencing growth due to the rising incidence of neurological disorders and increased efforts in research and development to enhance product innovation for improved diagnosis. Also, the incidence of brain aneurysms is increasing in several European nations. Moreover, governments are launching strategic initiatives which are aimed at treating patients with a brain aneurysm.
In the United Kingdom, brain aneurysms affect approximately 2-3% of the population. The prevalence of this condition is higher among women than men and is more frequently observed in the adult population. The incidence rate of subarachnoid hemorrhage caused by aneurysms in the UK is estimated to be around 7 cases per 100,000 individuals with sporadic aneurysms. Thus, the growing cases of brain aneurysm in the region, with regional authorities introducing initiatives to treat, and control the disease, the utilization of neurovascular catheters are expected to increase for treatment, driving the market expansion in the region.
The Germany market dominated the Europe Neurovascular Catheters Market by Country in 2022; thereby, achieving a market value of $319.2 million by 2029. The UK market is poised to grow at a CAGR of 5.5% during (2023 - 2029). Additionally, The France market would showcase a CAGR of 7.2% during (2023 - 2029).
Based on Type, the market is segmented into Embolization Catheters, Access Catheters, Balloon Catheters, Microcatheters and Others. Based on End-Use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on Application, the market is segmented into Brain Aneurysm, Embolic Stroke, Arteriovenous Malformations and Hydrolysate. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Neurovascular Catheters Market is Projected to reach USD 4.6 Billion by 2029, at a CAGR of 6.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, RAUMEDIC AG (REHAU Industries SE & Co. KG).
By Type
By End Use
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 